검색어: farmakolo (몰타어 - 영어)

proprjetajiet farmakolo ĠiĊi
pharmacological properties

tag rif farmakolo iku li a
pharmacological properties

l- attività farmakolo ika predominanti ejja minn olanzapine nnifsu.
the predominant pharmacologic activity is from the parent olanzapine.

farmakolo ika in vivo milli olanzapine fi studji fuq l- annimali.
cytochromes p450- cyp1a2 and p450-cyp2d6 contribute to the formation of the n-desmethyl and 2-hydroxymethyl metabolites, both exhibited significantly less in vivo pharmacological activity than olanzapine in animal studies.

glustin ie studjat fi studji klini i farmakolo i i u fi provi klini i.
glustin has been studied in clinical pharmacology studies and in clinical trials.

il- forma ba i libera ta ’ oxybutynin hija farmakolo ikament ekwivalenti g al oxybutynin hydrochloride.
the free base form of oxybutynin is pharmacologically equivalent to oxybutynin hydrochloride.

il- metaboli jinkludu phenylcyclohexylglycolic acid, li huwa farmakolo ikament inattiv, u n- desethyloxybutynin, li huwa farmakolo ikament attiv.
metabolites include phenylcyclohexylglycolic acid, which is pharmacologically inactive, and n-desethyloxybutynin, which is pharmacologically active.

informazzjoni li mhix klinika mag mula fuq studji konvenzjonali ta ’ sigurtà farmakolo ika, effett tossiku minn do i ripetuti, effett tossiku fuq il - eni, riskju ta ’ kan er, effett tossiku fuq is- sistema riproduttiva, ma turi l- ebda periklu spe jali g all- bnedmin.
non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction.